At a glance
ClinicalIndex Comparison RecordN/ACompleted· 585 enrolled
Drug / intervention
bimatoprost 0.03%drug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
An Observational Study of Patients Treated With Bimatoprost 0.03% (Latisse®) for Hypotrichosis of the Eyelashes
In Brief
An observational study evaluating bimatoprost 0.03% for Eyelash Hypotrichosis. Completed, enrolled 585 participants across 1 site.
Detailed Summary
This is an observational study of patients treated with bimatoprost 0.03% (Latisse®) for at least 12 months for hypotrichosis of the eyelashes.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsEyelash Hypotrichosis
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartNov 2010
Primary CompletionSep 2011
First PostedJun 2012
TodayJul 2026
First PostedJun 20, 2012
Enrollment StartNov 19, 2010
Primary CompletionSep 1, 2011
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 14.0 years ago
Interventions
bimatoprost 0.03%drug
Subjects with hypotrichosis of the eyelashes using bimatoprost 0.03% (Latisse®) as prescribed by physician for at least 12 months